HealthEquity surpasses fourth-quarter revenue expectations on robust HSA growth. It also provided fiscal 2026 guidance.

HQY stock wiped out its Trump election rally as the health savings account leader's earnings missed on elevated fraud costs.

HealthEquity stock drops after mixed Q4 results despite 18.8% revenue growth. Click here to find out why HQY stock is a Hold.

HealthEquity reported 19% revenue growth but missed Q4 EPS estimates. Analysts see earnings improving as cybersecurity costs ...

HealthEquity (HQY) stock dropped over 13% aftermarket trading following the company’s earnings announcement. Despite the decline, the company ...

Key Takeaways HealthEquity said it had added costs because of cyber threats and fraud attacks. The health savings account ...

The headline numbers for HealthEquity (HQY) give insight into how the company performed in the quarter ended January 2025, but it may be worthwhile to compare some of its key metrics to Wall Street ...

JMP Securities analyst Constantine Davides maintained a Buy rating on Healthequity (HQY – Research Report) today and set a price target of ...

HealthEquity (NASDAQ:HQY) is down nearly 15% in the past month, presenting a potential buying opportunity. The company ...

Analysts expect the Draper, Utah-based company to report quarterly earnings at 72 cents per share, up from 63 cents per share in the year-ago period. HealthEquity projects quarterly revenue of $305.82 ...